Daniel G Haller

Daniel G Haller

UNVERIFIED PROFILE

Are you Daniel G Haller?   Register this Author

Register author
Daniel G Haller

Daniel G Haller

Publications by authors named "Daniel G Haller"

Are you Daniel G Haller?   Register this Author

100Publications

2016Reads

46Profile Views

In memory of Dr. Henry T. Lynch.

Authors:
Daniel G Haller

Chin Clin Oncol 2019 Sep 3. Epub 2019 Sep 3.

Gastrointestinal Medical Oncology Professor Emeritus, Abramson Cancer Center at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.07.10DOI Listing
September 2019

Targeted therapy for metastatic colorectal cancer.

Expert Rev Anticancer Ther 2018 10 3;18(10):991-1006. Epub 2018 Aug 3.

n Medical Oncology , Cabrini Hospital and Monash University , Melbourne , Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1502664DOI Listing
October 2018

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis.

Expert Rev Anticancer Ther 2018 04 1;18(4):339-349. Epub 2018 Mar 1.

o Medical Oncology, University of Queensland , Brisbane , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1444481DOI Listing
April 2018

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

J Clin Oncol 2017 Nov 4;35(32):3671-3677. Epub 2017 Oct 4.

Charles S. Fuchs, Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT; Charles S. Fuchs, Peter C. Enzinger, Jeffrey Meyerhardt, and Robert J. Mayer, Dana-Farber/Partners CancerCare; Harvey J. Mamon and Richard S. Swanson, Brigham and Women's Hospital, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University; Christopher G. Willett, Duke Cancer Institute, Duke University Medical Center, Durham; Joel E. Tepper, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC; Daniel G. Haller, University of Pennsylvania, Philadelphia, PA; Tomislav Dragovich, Banner MD Anderson Cancer Center, Gilbert; Leonard L. Gunderson, Mayo Clinic, Scottsdale, AZ; Steven R. Alberts, Mayo Clinic, Rochester, MN; Georg A. Bjarnason, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Richard M. Goldberg and Kristen Ciombor, Ohio State University, James Cancer Hospital, Columbus, OH; Alan P. Venook, University of California at San Francisco, San Francisco, CA; David Ilson and Eileen O'Reilly, Memorial Sloan Kettering Cancer Center, New York, NY; and David J. Berg, University of Iowa/Holden Comprehensive Cancer Center, Iowa City, IA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.2130
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678342PMC
November 2017

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.

J Clin Oncol 2016 Apr 8;34(11):1182-9. Epub 2016 Feb 8.

Winson Y. Cheung, British Columbia Cancer Agency, Vancouver, British Columbia; Chris O'Callaghan, Queen's University, Kingston, Ontario, Canada; Lindsay A. Renfro, Axel Grothey, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; David Kerr, University of Oxford, Oxford; Chris Twelves, University of Leeds and St James Institute of Oncology, Leeds, United Kingdom; Aimery de Gramont, Franco-British Institute, Levallois-Perret; Thierry Andre, Hospital Saint-Antoine and Pierre and Marie Curie University, Paris; Jean-Francois Seitz, La Timone Hospital, Aix-Marseille University, Marseille, France; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Katherine A. Guthrie, Fred Hutchinson Cancer Center, Seattle, WA; Roberto Labianca, Ospedale Giovanni XXIII, Bergamo; Guido Francini, University of Siena, Siena, Italy; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933130PMC
April 2016

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

J Clin Oncol 2016 Mar 25;34(8):843-53. Epub 2016 Jan 25.

Manish A. Shah, Weill Cornell Medical College, New York/Presbyterian Hospital, New York, NY; Lindsay A. Renfro, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Carmen J. Allegra, University of Florida, Gainesville, FL; Thierry André, Hôpital Saint Antoine, Paris; Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle, Germany; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0558
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872008PMC
March 2016

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

J Clin Oncol 2015 Nov 31;33(32):3733-40. Epub 2015 Aug 31.

Hans-Joachim Schmoll, Martin Luther University, Halle, Germany; Josep Tabernero, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; Jean Maroun, Ottawa Regional Cancer Center, Ottawa, Ontario, Canada; Filippo de Braud, Istituto Europeo di Oncologia, Milan, Italy; Timothy Price, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia; Eric Van Cutsem, University Hospital Gasthuisberg, Leuven, Belgium; Mark Hill, Kent Oncology Centre, Maidstone, Kent, United Kingdom; Silke Hoersch, F. Hoffmann-La Roche, Basel, Switzerland; Karen Rittweger, F. Hoffmann-La Roche, Nutley, NJ; and Daniel G. Haller, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.9107DOI Listing
November 2015

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Expert Rev Anticancer Ther 2014 Dec 20;14(12):1477-93. Epub 2014 Aug 20.

The Queen Elizabeth Hospital, Adelaide Colorectal Tumour Group and University of Adelaide, Adeaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.949678DOI Listing
December 2014

Comparison of outcomes after fluorouracil-based adjuvant therapy for stages II and III colon cancer between 1978 to 1995 and 1996 to 2007: evidence of stage migration from the ACCENT database.

J Clin Oncol 2013 Oct 26;31(29):3656-63. Epub 2013 Aug 26.

Qian Shi, Axel Grothey, Brian M. Bot, and Daniel J. Sargent, North Central Cancer Treatment Group, Mayo Clinic, Rochester, MN; Thierry Andre, Hôpital Saint Antoine, Paris, France; Greg Yothers and Michael J. O'Connell, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh; Daniel G. Haller, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Stanley R. Hamilton, University of Texas MD Anderson Cancer Center, Houston, TX; Brian M. Bot, Sage Bionetworks; Jacqueline K. Benedetti, Southwest Oncology Group Statistical Center, Seattle, WA; Eric Van Cutsem, University Hospital Gasthuisberg, Gasthuisberg, Belgium; and Chris Twelves, St James's University Hospital, Leeds, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.4344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804289PMC
October 2013

Causes and management of early colorectal cancer.

Authors:
Daniel G Haller

Chin Clin Oncol 2013 Jun;2(2):11

Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.06.02DOI Listing
June 2013

Adjuvant therapy of stage III colon cancer.

Chin Clin Oncol 2013 Jun;2(2):17

Abramson Cancer Center at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.06.03DOI Listing
June 2013

Current opinion on optimal treatment for colorectal cancer.

Expert Rev Anticancer Ther 2013 May;13(5):597-611

The Queen Elizabeth Hospital, Adelaide Colorectal Tumour Group and University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.37DOI Listing
May 2013

A call for opinions.

Authors:
Daniel G Haller

Gastrointest Cancer Res 2013 Jan;6(1)

Gastrointestinal Cancer Research 200 Broadhollow Road, Suite 207 Melville, NY 11747.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597932PMC
January 2013

The Past and Future of GI Oncology Research.

Authors:
Daniel G Haller

Gastrointest Cancer Res 2012 Sep;5(5):147-8

Gastrointestinal Cancer Research 200 Broadhollow Road, Suite 207 Melville, NY 11747.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481145PMC
September 2012

Keep those cards and letters coming!

Authors:
Daniel G Haller

Gastrointest Cancer Res 2012 Mar;5(2):39

Gastrointestinal Cancer Research 200 Broadhollow Road, Suite 207 Melville, NY 11747.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369600PMC
March 2012

Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma.

Cancer 2011 Jul 24;117(14):3187-92. Epub 2011 Jan 24.

Abramson Cancer Center, Department of Medicine, Hematology-Oncology Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25889DOI Listing
July 2011

Must Reading for GI Oncologists.

Authors:
Daniel G Haller

Gastrointest Cancer Res 2011 Jul;4(4):115

Gastrointestinal Cancer Research 200 Broadhollow Road, Suite 207 Melville, NY 11747.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283106PMC
July 2011

The heart of the matter.

Authors:
Daniel G Haller

Gastrointest Cancer Res 2011 May;4(3):77

Gastrointestinal Cancer Research , 200 Broadhollow Road, Suite 207, Melville, NY 11747.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201638PMC
May 2011

Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program.

J Clin Oncol 2010 Feb 19;28(4):527-30. Epub 2009 Oct 19.

Hôpital Saint Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.2544DOI Listing
February 2010

What Makes GI Oncology Special?

Authors:
Daniel G Haller

Gastrointest Cancer Res 2009 Nov;3(6):219

Professor of Medicine, Deenie Greitzer Professor of Gastrointestinal Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000067PMC
November 2009

Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease.

Oncologist 2009 Oct 9;14(10):963-9. Epub 2009 Oct 9.

University of Pennsylvania, Abramson Cancer Center at Penn Presbyterian Medical Center, 51 North 39th Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0022DOI Listing
October 2009

Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?

Clin Colorectal Cancer 2009 Oct;8(4):194-9

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CCC.2009.n.033DOI Listing
October 2009

Thoughts on the Coming Year, ISGIO, and the Future of GI Oncology.

Authors:
Daniel G Haller

Gastrointest Cancer Res 2009 Sep;3(5):177

Daniel G. Haller, MD, President, ISGIO, Professor of Medicine, Deenie Greitzer Professor of Gastrointestinal Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806799PMC
September 2009

Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer.

Nat Rev Clin Oncol 2009 May;6(5):250-1

Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.46DOI Listing
May 2009

Provisional clinical opinion.

J Clin Oncol 2009 Apr 13;27(12):1925. Epub 2009 Mar 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.3925DOI Listing
April 2009

Gastrointestinal stromal tumors and neuroendocrine tumors.

Semin Oncol Nurs 2009 Feb;25(1):48-60

Abramson Cancer Center, Hospital of the University of Pennsylvania, Division of Medicine, Department of Hematology-Oncology, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soncn.2008.10.004DOI Listing
February 2009

Clinical trials registration: will your study be publishable?

Authors:
Daniel G Haller

J Clin Oncol 2009 Jan 24;27(1). Epub 2008 Nov 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.9382DOI Listing
January 2009

Bevacizumab beyond progression: does this make sense?

J Clin Oncol 2008 Nov 14;26(33):5313-5. Epub 2008 Oct 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.4540DOI Listing
November 2008

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

J Clin Oncol 2008 May;26(14):2336-41

National Surgical Adjuvant Breast and Bowel Project Operations Office, Pittsburgh, PA 15212-5234, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.8261DOI Listing
May 2008

Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.

Gastrointest Cancer Res 2008 May;2(3 Suppl):S2-6

Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664907PMC
May 2008

Accomplishments in gastrointestinal oncology in 2007: conclusion.

Gastrointest Cancer Res 2008 May;2(3 Suppl):S57

Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664913PMC
May 2008

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.

Cancer 2007 Dec;110(12):2768-74

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23098DOI Listing
December 2007

Colorectal cancer treatment in the elderly: tailored therapy approaches.

Gastrointest Cancer Res 2007 Nov;1(6):254-5

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631217PMC
November 2007

Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

Gastrointest Cancer Res 2007 Jul;1(4):146-54

Departments of Medicine and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632523PMC
July 2007

Metastatic PEComa arising from renal angiomyolipoma: MRI findings.

J Magn Reson Imaging 2007 Jul;26(1):159-61

Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.20947DOI Listing
July 2007

Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.

Cancer 2006 Aug;107(4):676-85

Department of Medicine/Clinical Pharmacology, New York University Cancer Institute, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22036
Publisher Site
http://dx.doi.org/10.1002/cncr.22036DOI Listing
August 2006

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

J Clin Oncol 2006 Feb;24(4):663-7

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.2994DOI Listing
February 2006

JCO and the Public Trust.

Authors:
Daniel G Haller

J Clin Oncol 2006 Jan 19;24(3):323-4. Epub 2005 Dec 19.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.1714DOI Listing
January 2006

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

J Clin Oncol 2005 Dec;23(34):8706-12

Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.8852DOI Listing
December 2005

Adjuvant therapy for colon cancer.

Curr Oncol Rep 2005 May;7(3):181-5

Abramson Cancer Center, University of Pennsylvania, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
May 2005

Adjuvant therapy of colon cancer.

Semin Oncol 2005 Feb;32(1):95-102

Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2004.09.037DOI Listing
February 2005

Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers.

Authors:
Daniel G Haller

Semin Oncol 2004 Dec;31(6 Suppl 14):10-6

Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2004.11.006DOI Listing
December 2004

Future directions with angiogenesis inhibitors in colorectal cancer.

Clin Colorectal Cancer 2004 Oct;4 Suppl 2:S86-93

University of Pennsylvania Cancer Center, 3400 Spruce St, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
October 2004

Physician-nurse collaboration in research in the 21st century.

J Clin Oncol 2004 Mar;22(5):774-6

University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.08.188DOI Listing
March 2004

Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 days.

Clin Cancer Res 2003 Nov;9(14):5221-7

Abrahmson Family Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
November 2003

Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.

Ann Intern Med 2003 Oct;139(8):649-57

Dana-Farber Cancer Institute, Eastern Cooperative Oncology Group Statistical Center, and Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00008DOI Listing
October 2003

Chemotherapy for advanced pancreatic cancer.

Authors:
Daniel G Haller

Int J Radiat Oncol Biol Phys 2003 ;56(4 Suppl):16-23

Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0360-3016(03)00448-6DOI Listing
August 2003

New perspectives in the management of pancreas cancer.

Authors:
Daniel G Haller

Semin Oncol 2003 Aug;30(4 Suppl 11):3-10

Department of Medicine, The Abramson Cancer Center at the University of Pennsylvania, Philadelphia 19104-4283, USA.

View Article

Download full-text PDF

Source
August 2003

COX-2 inhibitors in oncology.

Authors:
Daniel G Haller

Semin Oncol 2003 Aug;30(4 Suppl 12):2-8

University of Pennsylvania Cancer Center, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
August 2003

Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.

Cancer 2003 Apr;97(8):1985-90

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11273DOI Listing
April 2003

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection.

Ann Surg Oncol 2003 Apr;10(3):213-8

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/aso.2003.03.059DOI Listing
April 2003

Rhabdomyolysis from cytochrome p-450 interaction of ketoconazole and simvastatin in prostate cancer.

J Urol 2003 Feb;169(2):613

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000043761.61046.b0DOI Listing
February 2003

Impact of diabetes mellitus on outcomes in patients with colon cancer.

J Clin Oncol 2003 Feb;21(3):433-40

Dana-Farber Cancer Institute, Eastern Cooperative Oncology Group Statistical Center, and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/21/3/433.full.pdf
Web Search
http://dx.doi.org/10.1200/JCO.2003.07.125DOI Listing
February 2003

Future directions in the treatment of pancreatic cancer.

Authors:
Daniel G Haller

Semin Oncol 2002 Dec;29(6 Suppl 20):31-9

University of Pennsylvania Cancer Center, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2002.37381DOI Listing
December 2002

Chemotherapy for colorectal cancer.

Hematol Oncol Clin North Am 2002 Aug;16(4):969-94

Hematology/Oncology Division, Univeristy of Pennsylvania Medical Center, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
August 2002